Wein Matthew
Known title: See RemarksCIK: 0002009713
Associated companies
Transaction History
| MGX | ▼ Sell | Open Market | 358 | $415 | 9/8/2026 | View on chart |
| MGX | ▼ Sell | Open Market | 558 | $725 | 6/5/2026 | View on chart |
| MGX | ▲ Buy | Grant | 11,000 | $0 | 4/1/2026 | View on chart |
| MGX | ▼ Sell | Open Market | 482 | $771 | 3/5/2026 | View on chart |
| MGX | ▼ Sell | Open Market | 199 | $353 | 12/5/2025 | View on chart |
| MGX | ▲ Buy | Grant | 96,000 | $154K | 12/1/2025 | View on chart |
| MGX | ▼ Sell | Open Market | 199 | $360 | 9/5/2025 | View on chart |
| MGX | ▼ Sell | Open Market | 199 | $348 | 6/6/2025 | View on chart |
| MGX | ▲ Buy | Grant | 3,775 | $0 | 4/1/2025 | View on chart |
| MGX | ▲ Buy | Grant | 3,650 | $0 | 4/1/2025 | View on chart |
| MGX | ▼ Sell | Open Market | 930 | $2K | 3/5/2025 | View on chart |
| MGX | ▲ Buy | Grant | 10,397 | $0 | 4/1/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Metagenomi Therapeutics to Speak at Chardan Healthcare Conference
Metagenomi Therapeutics announced it will participate in the Chardan 10th Annual Healthcare Conference. This event provides a platform for the company to share updates with industry professionals and investors. The stock is currently trading near its 52-week low, making this upcoming presentation a notable point of interest for observers tracking the company's developments.
Metagenomi Therapeutics to Speak at Chardan Healthcare Conference. Metagenomi Therapeutics announced it will participate in the Chardan 10th Annual Healthcare Conference. This event provides a platform for the company to share updates with industry professionals and investors. The stock is currently trading near its 52-week low, making this upcoming presentation a notable point of interest for observers tracking the company's developments.